Managing bronchiolitis in pediatric patients: Current evidence

Background: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent...

Full description

Bibliographic Details
Main Authors: Subhranshu Sekhar Dhal, Hiremath Sagar
Format: Article
Language:English
Published: Jaypee Brothers Medical Publisher 2022-01-01
Series:Indian Journal of Respiratory Care
Subjects:
Online Access:http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhal
_version_ 1797697914948026368
author Subhranshu Sekhar Dhal
Hiremath Sagar
author_facet Subhranshu Sekhar Dhal
Hiremath Sagar
author_sort Subhranshu Sekhar Dhal
collection DOAJ
description Background: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent evidence in the management of bronchiolitis. Methods: PubMed, EMBASE, Global Health, MEDLINE, SCOPUS, and Cochrane database searches were performed using keywords such as bronchiolitis, management, bronchodilators, nebulized epinephrine, corticosteroids, and hypertonic saline. Systematic reviews, original articles, and clinical practice guidelines with evidence for bronchiolitis management were included during our search. We excluded guidelines and clinical trials which solely focused on high-risk children, articles by a single author, and trials that are not part of a clinical practice guideline. Discussion: The safety and efficacy of various therapies for bronchiolitis such as bronchodilators, epinephrine, hypertonic saline, and corticosteroid were analyzed. Bronchodilators have not shown consistent benefits in bronchiolitis and may be tried in the selected population. Current evidence does not suggest routine use of nebulized epinephrine in bronchiolitis except as rescue therapy in selected cases. Hypertonic saline showed positive results in some studies but questions still remain regarding its effectiveness in all. Recent trials also do not support the use of systemic or inhaled corticosteroids in bronchiolitis. Conclusion: In conclusion, there is no strong evidence to routinely recommend the use of bronchodilator, epinephrine, hypertonic saline, or corticosteroids in acute bronchiolitis. Supportive care still remains the mainstay of therapy for bronchiolitis.
first_indexed 2024-03-12T03:46:46Z
format Article
id doaj.art-b0c138abfa9844d4bca6542809311170
institution Directory Open Access Journal
issn 2277-9019
2321-4899
language English
last_indexed 2024-03-12T03:46:46Z
publishDate 2022-01-01
publisher Jaypee Brothers Medical Publisher
record_format Article
series Indian Journal of Respiratory Care
spelling doaj.art-b0c138abfa9844d4bca65428093111702023-09-03T12:43:45ZengJaypee Brothers Medical PublisherIndian Journal of Respiratory Care2277-90192321-48992022-01-0111429129510.4103/ijrc.ijrc_153_22Managing bronchiolitis in pediatric patients: Current evidenceSubhranshu Sekhar DhalHiremath SagarBackground: Acute bronchiolitis is an inflammatory process affecting small airways. Although most cases are self-limiting, it is still one of the most common causes of hospitalization below 24 months of age. Treatment is mainly supportive. The purpose of this narrative review was to look for recent evidence in the management of bronchiolitis. Methods: PubMed, EMBASE, Global Health, MEDLINE, SCOPUS, and Cochrane database searches were performed using keywords such as bronchiolitis, management, bronchodilators, nebulized epinephrine, corticosteroids, and hypertonic saline. Systematic reviews, original articles, and clinical practice guidelines with evidence for bronchiolitis management were included during our search. We excluded guidelines and clinical trials which solely focused on high-risk children, articles by a single author, and trials that are not part of a clinical practice guideline. Discussion: The safety and efficacy of various therapies for bronchiolitis such as bronchodilators, epinephrine, hypertonic saline, and corticosteroid were analyzed. Bronchodilators have not shown consistent benefits in bronchiolitis and may be tried in the selected population. Current evidence does not suggest routine use of nebulized epinephrine in bronchiolitis except as rescue therapy in selected cases. Hypertonic saline showed positive results in some studies but questions still remain regarding its effectiveness in all. Recent trials also do not support the use of systemic or inhaled corticosteroids in bronchiolitis. Conclusion: In conclusion, there is no strong evidence to routinely recommend the use of bronchodilator, epinephrine, hypertonic saline, or corticosteroids in acute bronchiolitis. Supportive care still remains the mainstay of therapy for bronchiolitis.http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhalbronchiolitisbronchodilatorepinephrinehypertonic saline
spellingShingle Subhranshu Sekhar Dhal
Hiremath Sagar
Managing bronchiolitis in pediatric patients: Current evidence
Indian Journal of Respiratory Care
bronchiolitis
bronchodilator
epinephrine
hypertonic saline
title Managing bronchiolitis in pediatric patients: Current evidence
title_full Managing bronchiolitis in pediatric patients: Current evidence
title_fullStr Managing bronchiolitis in pediatric patients: Current evidence
title_full_unstemmed Managing bronchiolitis in pediatric patients: Current evidence
title_short Managing bronchiolitis in pediatric patients: Current evidence
title_sort managing bronchiolitis in pediatric patients current evidence
topic bronchiolitis
bronchodilator
epinephrine
hypertonic saline
url http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=4;spage=291;epage=295;aulast=Dhal
work_keys_str_mv AT subhranshusekhardhal managingbronchiolitisinpediatricpatientscurrentevidence
AT hiremathsagar managingbronchiolitisinpediatricpatientscurrentevidence